venBio Select Advisor LLC Has $41.27 Million Stake in Tricida Inc (TCDA)

venBio Select Advisor LLC trimmed its stake in shares of Tricida Inc (NASDAQ:TCDA) by 1.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,750,000 shares of the company’s stock after selling 21,500 shares during the quarter. Tricida makes up 2.5% of venBio Select Advisor LLC’s portfolio, making the stock its 13th biggest position. venBio Select Advisor LLC’s holdings in Tricida were worth $41,265,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Legal & General Group Plc bought a new position in Tricida during the 3rd quarter valued at $54,000. Great West Life Assurance Co. Can bought a new position in Tricida during the 4th quarter valued at $71,000. Strs Ohio bought a new position in Tricida during the 3rd quarter valued at $100,000. Wells Fargo & Company MN bought a new position in Tricida during the 3rd quarter valued at $170,000. Finally, New York State Common Retirement Fund bought a new position in Tricida during the 4th quarter valued at $211,000. Hedge funds and other institutional investors own 70.27% of the company’s stock.

Shares of NASDAQ:TCDA traded up $0.13 on Friday, reaching $24.87. 34,671 shares of the company’s stock were exchanged, compared to its average volume of 161,212. Tricida Inc has a fifty-two week low of $19.43 and a fifty-two week high of $40.10. The company has a debt-to-equity ratio of 0.11, a current ratio of 12.68 and a quick ratio of 12.68.

In related news, insider Claire Lockey sold 10,000 shares of the stock in a transaction dated Wednesday, December 26th. The shares were sold at an average price of $25.06, for a total value of $250,600.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Klaus R. Dr Veitinger sold 9,814 shares of the stock in a transaction dated Wednesday, December 26th. The stock was sold at an average price of $24.97, for a total transaction of $245,055.58. The disclosure for this sale can be found here. Insiders have sold 39,135 shares of company stock worth $929,740 over the last three months.

Separately, Zacks Investment Research raised shares of Tricida from a “hold” rating to a “buy” rating and set a $26.00 target price on the stock in a report on Thursday, January 10th.

COPYRIGHT VIOLATION WARNING: “venBio Select Advisor LLC Has $41.27 Million Stake in Tricida Inc (TCDA)” was first posted by WKRB News and is owned by of WKRB News. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://www.wkrb13.com/2019/03/15/venbio-select-advisor-llc-has-41-27-million-stake-in-tricida-inc-tcda.html.

Tricida Profile

Tricida, Inc operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer drug that has completed Phase III clinical trials to treat metabolic acidosis in patients with chronic kidney disease. The company was founded in 2013 and is headquartered in South San Francisco, California.

Featured Story: Why do companies issue convertible shares?

Want to see what other hedge funds are holding TCDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tricida Inc (NASDAQ:TCDA).

Institutional Ownership by Quarter for Tricida (NASDAQ:TCDA)

Receive News & Ratings for Tricida Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tricida and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply